Biofrontera Inc.

The momentum for this stock is not very good. Biofrontera Inc. is not a good value stock. Biofrontera Inc. has good growth characteristics. Biofrontera Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Biofrontera Inc..

News

Biofrontera Inc. (NASDAQ:BFRI) Short Interest Up 11.0% in July

Ticker Report Biofrontera Inc. (NASDAQ:BFRI - Get Free Report) was the target of a large increase in short interest in the month of July. As of July 31st, there was short interest totalling 38,500 shares, an...\n more…

Benchmark Reaffirms Buy Rating for Biofrontera (NASDAQ:BFRI)

Ticker Report Benchmark reaffirmed their buy rating on shares of Biofrontera (NASDAQ:BFRI - Free Report) in a report issued on Friday, Benzinga reports. Benchmark currently has a $7.00 price target on the stock...\n more…

Biofrontera Inc. (BFRI) Q2 2024 Earnings Call Transcript

Seeking Alpha: Transcripts Biofrontera Inc. (BFRI) Q2 2024 Earnings Call Transcript...\n more…

BFRI Stock Earnings: Biofrontera Beats EPS, Misses Revenue for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nBFRI stock results show that Biofrontera beat analyst estimates for earnings per share but missed on revenue for the second quarter of...\n more…

Biofrontera Inc. reports Q2 EPS (5c), consensus (77c)

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update

Globe Newswire Woburn, MA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today...\n more…